China Digest: New Vision, Coherent Biopharma snap funding
Shunwei Capital-backed New Vision has raised $28.7 million in a Series D round, while Coherent Biopharma has secured $100 million in Series B and B+ rounds.
Source: dealstreetasia.com
Stay updated with breaking news from Hefei High Tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shunwei Capital-backed New Vision has raised $28.7 million in a Series D round, while Coherent Biopharma has secured $100 million in Series B and B+ rounds.